FDA Clearance Tracker · P950021
ADVIA CENTAUR & ADVIA CENTAUR CP PSA IMMUNOASSAY
Last checked: Nov 20, 2026Latest source record: Dec 22, 1995 (this decision)Source: openFDAMethods & limitations
Decided
Dec 22, 1995
Approved
Time to decision
178 days
Received Jun 27, 1995. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P950021
- Device name
- ADVIA CENTAUR & ADVIA CENTAUR CP PSA IMMUNOASSAY
- Applicant
- Siemens Healthcare Diagnostics
- Applicant location
- East Walpole, MA
- Received
- Jun 27, 1995
- Decided
- Dec 22, 1995
- Decision
- Approved
- Supplements
- 29 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- Laboratory Medicine & Pathology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE TECHNICON IMMUNO 1 PSA ASSAY - THIS DEVICE IS AN IN VITRO DIAGNOSTIC DEVICE
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code MTG (Test, prostate specific antigen, free, (noncomplexed) to distinguish prostate cancer from benign conditions).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Siemens Healthcare Diagnostics
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260674 · Decided Nov 6, 2026 · 249 days after receipt
Device type: System, Test, Vitamin D (MRG) · Laboratory Medicine & Pathology
K260400 · Decided Nov 2, 2026 · 269 days after receipt
Device type: System, Test, Radioallergosorbent (Rast) Immunological (DHB) · Laboratory Medicine & Pathology
K260331 · Decided Sep 4, 2026 · 214 days after receipt
Device type: System, Test, Radioallergosorbent (Rast) Immunological (DHB) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.